KMX vs TTRX · P/E 19, rev $25.88B vs $187.1M cap
CarMax Inc (KMX) versus Turn Therapeutics Inc. Common Stock (TTRX) — a side-by-side from cached financials, not a winner call.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Latest reported KMX revenue for 2026-02-28 was $25.88B. Net income was $247.3M. Revenue was down 1.8% from 2025-02-28 to 2026-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
TTRX does not have a complete income-statement cache yet.
KMX currently screens at market cap $10.26B and trailing P/E 18.9. TTRX currently screens at market cap $187.1M.
Not investment advice. Open the KMX and TTRX stock pages for the full models.
Not investment advice.